Posted: Thu Jan 08, 2009 9:17 am Post subject: Medicago Expands H5N1 Canadian Vax Plant
Medicago is investing $1.5m to expand its manufacturing facility in Quebec, Canada, as it attempts to ramp up production to ensure supply for its clinical trials.
The 2,500 sq ft expansion is intended to help Medicago produce enough of its H5N1 pandemic vaccine candidate for Phase II trials. Medicago has also acquired 100,000 sq ft of land adjacent to its current facility that will be used for further expansions in the next three years.
You cannot post new topics in this forum You cannot reply to topics in this forum You cannot edit your posts in this forum You cannot delete your posts in this forum You cannot vote in polls in this forum